ARCHIVES

Two Phase II Studies of Ibrutinib Deliver High Response Rates

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

Rimer, Boxer Reappointed to NCAB; 4 Others Named

June 28, 1996

Reynolds Unveils New Cigarette ; Cullen, Others Skeptical

September 18, 1987

Rauscher To Become ACS VP For Research Nov. 1; Search Starts for New NCI Director

September 24, 1976

In Brief: Laird Myers Heads AACE, George Hill President Elect; Cal Tech’s Hood Receives Bertner Award

March 1, 1985

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980